CLINICAL_TRIALS
trial_result
· 2022-06-29
Clinical Trial Update: Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy [Phase 2]
Summary
Phase 2 clinical trial update on Nidufexor in diabetic nephropathy reports safety, tolerability, and efficacy outcomes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Diabetic Nephropathy | Phase 2 | Status: COMPLETED | Results posted: 2022-06-29